-
$2500.00
-
1 mg
Description
The global market for nanobiotechnology should grow from $38.5 billion in 2021 to $68.4 billion by 2026, at compound annual growth rate (CAGR) of 12.2% for the period of 2021-2026. The scope of this investigation includes the major viable nanobiotechnologies that are currently being implemented in various industries. The study scope includes the major nanotechnology formats that will or likely to become commercialized within the next 5 years. Each technology format is analyzed to determine its market status, impact on future market segments and forecasted growth from 2021 through 2026. Technology issues and market-driving forces are discussed. Influencing factors, including drug delivery needs, biologic imaging trends and industry structure, are also discussed. BCC Research examines nanobiotechnology companies and industry alliances, nanomaterial consumption, end-user industry, and market-driving forces.
Price History
Related Deals
US Biosimilars Market Analysis
-
$3999.00
-
1 mg
US Biosimilars Market Analysis
-
$3999.00
-
1 mg